TG Therapeutics Reports Strong Revenue, Shares Surge Despite Market Decline
TG Therapeutics shares surged 11.6% to $31.10 following the announcement of a preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million.
The strong financial performance, despite a broader market decline with the Nasdaq Composite falling over 200 points, showcases TG Therapeutics' competitiveness in the biopharmaceutical sector. The preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
This optimistic outlook is expected to boost shareholder confidence and attract more capital inflow, positioning TG Therapeutics favorably in a challenging market environment.
Trade with 70% Backtested Accuracy
Analyst Views on ADNT
About ADNT
About the author

- Earnings Announcement: Adient (ADNT) is set to announce its Q2 earnings on May 6th before market open, with consensus EPS estimate at $0.44, reflecting a 36.2% year-over-year decline, while revenue is projected at $3.63 billion, a modest 0.8% increase, indicating both challenges and opportunities in the current economic landscape.
- Historical Performance: Over the past two years, Adient has beaten EPS estimates 63% of the time and revenue estimates 63% of the time, demonstrating a degree of stability and adaptability in its financial performance amidst market fluctuations.
- Estimate Revision Trends: In the last three months, EPS estimates have seen one upward revision and nine downward revisions, while revenue estimates experienced three upward revisions and five downward revisions, reflecting a cautious market sentiment regarding Adient's future performance, which may impact investor confidence.
- Industry Context: In the upcoming earnings report, Adient may benefit from increased production of F-series vehicles and demand for
- Profit Reversal: Adient PLC reported a net income of $27 million in Q2 2023, a significant turnaround from a loss in the same period last year, indicating strong performance amid market recovery.
- Earnings Beat Expectations: The company posted earnings of 34 cents per share, with adjusted earnings at 52 cents, surpassing Wall Street's forecast of 37 cents, reflecting improved operational efficiency.
- Revenue Growth: Adient's revenue reached $3.87 billion for the quarter, exceeding analyst expectations of $3.57 billion, demonstrating robust demand in the automotive seating and interiors market.
- Stock Performance: Adient's shares have risen nearly 8% since the beginning of the year and have increased 61% over the past 12 months, showcasing investor confidence in the company's growth potential.
- Financial Overview: Adient announced its Q2 2026 financial results, although specific figures were not disclosed, the company's strong leadership in the global automotive seating market is expected to continue attracting investor interest.
- Investor Conference Call: CEO Jerome Dorlack and CFO Mark Oswald will host a conference call at 8:30 AM Eastern to discuss the financial results, which is anticipated to provide in-depth analysis of future performance.
- Global Operational Scale: With over 65,000 employees across 29 countries and approximately 200 manufacturing and assembly plants, Adient demonstrates its robust capabilities and market coverage in automotive seating production.
- Cautionary Forward-Looking Statements: The company highlighted various risks associated with its forward-looking statements, including economic fluctuations and supply chain challenges, urging investors to carefully assess these factors' potential impacts on future performance.
- Acquisition Expansion: Adient announced the acquisition of a foam plant in Romulus, Michigan, which will enhance its operational capabilities as a key auto supplier and further solidify its market position in the Americas.
- Supply Chain Integration: The plant supplies seat foam to multiple automakers and is now part of Adient's Americas network, improving integration efficiency among its 30 global facilities.
- Comprehensive Asset Transfer: The deal includes land, buildings, inventory, and equipment, ensuring the retention of existing employees, which minimizes integration risks and facilitates a smooth transition into Adient's operations.
- Optimistic Market Outlook: This acquisition positions Adient to better meet the growing automotive market demand, particularly in F-series production and
- Strategic Expansion: Adient's acquisition of the foam production plant in Romulus enhances its operational footprint, increasing its foam plants in the Americas to 11 and globally to 30, thereby strengthening its competitive position in the automotive seating market.
- Acquisition Details: The deal includes the purchase of the existing building, land, production equipment, inventory, and associated assets, ensuring the current workforce remains employed and the collective bargaining agreement with the UAW stays intact, reflecting Adient's commitment to its employees.
- Market Impact: This acquisition not only boosts Adient's production capacity but also solidifies its position as a preferred supplier and employer in the automotive seating sector, which is expected to enhance customer satisfaction and market share.
- Global Network: With approximately 200 manufacturing/assembly plants worldwide and over 65,000 employees, this acquisition will help optimize Adient's global supply chain, improving overall operational efficiency and responsiveness.
- Strategic Expansion: Adient's acquisition of the foam production plant in Romulus enhances its operational footprint, adding to its existing network of 10 foam plants in the Americas and strengthening its competitive position in the automotive seating market.
- Acquisition Details: The agreement includes the purchase of the existing building, land, production equipment, inventory, and associated assets, ensuring job security for current employees and maintaining the collective bargaining agreement with the UAW, reflecting the company's commitment to its workforce.
- Global Presence: With 30 foam manufacturing plants worldwide, this acquisition not only boosts Adient's production capacity but also solidifies its market position as a leading automotive seating supplier, enhancing customer trust and reliability.
- Management Insight: Jim Conklin, Adient's Executive Vice President for the Americas, stated that this acquisition will positively impact customers, showcasing the company's global scale and expertise in automotive seating, further establishing its role as a preferred supplier and employer.







